ArticleScientific reports2018

Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis.

K Griffiths et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.